Physician profile

Bassem Onsy Abraham

Pain Medicine · Trumbull, CT

NPI 1922180520

$4,610.22

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$1,505.71
Food and Beverage$73.45

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $1,555.21 2023
Spinal Simplicity, LLC $1,219.85 2022
Mml US, INC. $939.15 2022
Relievant Medsystems, INC. $729.79 2020
Abbott Laboratories $119.74 2020
Bioventus LLC $23.95 2023 Stimrouter Implantable Kit
Impel Pharmaceuticals INC. $22.53 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bassem Onsy Abraham

$4,610.22

in general payments reported 2019-2025

Years
2020-2023
Top company
Boston Scientific Corporation

https://glasscript.com/doctor/42195/bassem-onsy-abraham

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.